Boost your GCP E6 (R3) exam readiness. Improve your understanding with engaging, insightful questions. Test yourself with hints and detailed explanations. Prepare effectively!

Multiple Choice

Which of the following best describes ongoing safety updates that should be submitted?

Ongoing safety reporting is a continuous obligation in clinical trials. As new information about risks or adverse events becomes available, the sponsor or investigator must submit safety updates to the ethics committee and, when required, to regulatory authorities. These updates, which include SUSARs and safety summaries, ensure that the risk-benefit assessment is current and that participants remain protected. This process is distinct from recruitment advertisements (which relate to enrolling participants), investigator qualifications (which concern personnel), or protocol amendments (which are changes to the study plan). So, the ongoing safety updates are what should be submitted to oversight bodies.

Ongoing safety reporting is a continuous obligation in clinical trials. As new information about risks or adverse events becomes available, the sponsor or investigator must submit safety updates to the ethics committee and, when required, to regulatory authorities. These updates, which include SUSARs and safety summaries, ensure that the risk-benefit assessment is current and that participants remain protected. This process is distinct from recruitment advertisements (which relate to enrolling participants), investigator qualifications (which concern personnel), or protocol amendments (which are changes to the study plan). So, the ongoing safety updates are what should be submitted to oversight bodies.